- BS, Chemistry, BA in Spanish Language: Pacific Union College, Angwin CA (2008)
- Medical Degree: State University of New York, University at Buffalo, Buffalo, NY (2015)
- Doctor of Philosphy, Microbiology and Immunology: State University of New York, University at Buffalo, Buffalo, NY (2015)
- Residency: Barnes-Jewish Hospital at Washington University Medical School, St. Louis (2017)
Laura Marks, MD, PhD
Instructor in Medicine
Dr. Marks specializes in clinical infectious diseases with a special focus on infectious complications in people who inject drugs. She attends on the general infectious diseases consult service teaching fellows, residents, and students. She also sees patients in infectious diseases outpatient clinic where she oversees the Bridge to Health program for patients with injection drug use associated infections. The Bridge to Health program provides outpatient infectious diseases and substance use disorder care with additional multidisciplinary support including case management and health coaches. The Bridge to health program has a special emphasis on providing hepatitis C treatment as well as flexible antibiotic options (OPAT and transition to oral antibiotics) for patients with serious injection related infections such as endocarditis and osteomyelitis. She is currently mentoring fellows and residents.
- Marks LR, Liang SY, Muthulingam D, Schwarz E, Liss D, Munigala S, Warren D, Durkin M, Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections, Clin Infect Dis 2020; https://doi.org/10.1093/cid/ciaa365. PMID: 32239136
- Marks LR, Schwarz, Liss D, Munigala S, Warren DK, Liang SY, Durkin MJ. A Comparison of Medication Assisted Therapy Treatment Strategies for Opioid Use Disorder in Persons who Inject Drugs and are Hospitalized with Serious Infections. Infect. Dis. 2020. PMCID: PMC7566615.
- Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis. 2018 Oct 23. doi: 10.1093/cid/ciy924. PMID: 30357363.